£

What we do and why it matters

Funding research is at the heart of what we do, made possible solely because of our community's generosity.

Our funding has supported many advances in therapies for blood cancer, including the development of new drugs for chronic myeloid leukaemia (CML) and acute lymphoblastic leukaemia (ALL), antibody treatments for lymphoma.

New classes of therapies are being developed all the time. There are huge opportunities to develop new therapies that improve and save the lives of everyone with blood cancer.

Charlotte Graham, researcher at Kings College London, smiling in her Blood Cancer UK lab coat.

65 years of impact

Our latest impact report highlights the progress we have made over the past 65 years: how it's transformed lives and how it's brought us closer to the day where no one dies of blood cancer or its treatments.

Read our impact report

Our impact in numbers

We've invested over £500 million in research in the last 65 years. This has led to countless new treatments and has transformed the lives of people with blood cancer.

  • £500 million Invested into blood cancer research

  • 2300+ Over 2300 research projects

  • £65 million+ Invested in studentships and fellowships

  • £35 million Invested into clinical trials

accurate as of July 2025
A researcher in a Blood Cancer UK funded lab, looking through a microscope.

For researchers

Discover our open calls and application guidance. We offer grants for a range of research, from discovery to clinical research - plus support for early career researchers through our fellowship scheme.

Apply for funding and more
Alyssa and mum, Kiona, outside, facing each other and laughing as they embrace.

"So many people behind the scenes have made this happen, people in their labs, like Professor Waseem. Alyssa wouldn't be here today without Blood Cancer UK…because there was nothing else out there except for this clinical trial. It does make a difference. It makes a huge difference."

Kiona, Alyssa’s Mum Alyssa's story

Help us beat blood cancer within a generation

  • Could help eight people newly diagnosed with blood cancer understand their condition.
  • Could allow researchers to analyse blood cancer cells which will help to create new treatments and improve early diagnosis.
  • Could help scientists to look at genetic patterns in tumour samples, to better understand how genes can play a part in the development of blood cancer.
Donate